232 related articles for article (PubMed ID: 31999044)
21. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
22. Alfapump
Weil-Verhoeven D; Di Martino V; Stirnimann G; Cervoni JP; Nguyen-Khac E; Thévenot T
World J Hepatol; 2022 Jul; 14(7):1344-1356. PubMed ID: 36158913
[TBL] [Abstract][Full Text] [Related]
23. Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts.
Gülberg V; Liss I; Bilzer M; Waggershauser T; Reiser M; Gerbes AL
Digestion; 2002; 66(2):127-30. PubMed ID: 12428073
[TBL] [Abstract][Full Text] [Related]
24. Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.
Allegretti AS; Ortiz G; Cui J; Wenger J; Bhan I; Chung RT; Thadhani RI; Irani Z
Am J Kidney Dis; 2016 Sep; 68(3):381-91. PubMed ID: 26994685
[TBL] [Abstract][Full Text] [Related]
25. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
Garcia-Tsao G
Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
[TBL] [Abstract][Full Text] [Related]
26. Surgical technique for placement of the automated low flow ascites pump (Alfapump).
Dembinski J; Aranovich D; Banz V; Ehmann T; Klein I; Malago M; Richter N; Schnitzbauer AA; Staszewicz W; Tautenhahn HM; Capel J; Regimbeau JM
Langenbecks Arch Surg; 2020 Feb; 405(1):117-123. PubMed ID: 31915920
[TBL] [Abstract][Full Text] [Related]
27. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.
Stirnimann G; Banz V; Storni F; De Gottardi A
Therap Adv Gastroenterol; 2017 Feb; 10(2):283-292. PubMed ID: 28203285
[TBL] [Abstract][Full Text] [Related]
28. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
Ainsworth MA; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
[No Abstract] [Full Text] [Related]
29. Novel Innovations in Ascites Management.
Siemers KM; Stjernholm JD; Pocha C
S D Med; 2023 Mar; 76(3):116-119. PubMed ID: 36898197
[TBL] [Abstract][Full Text] [Related]
30. Management of ascites in cirrhosis.
Wong F
J Gastroenterol Hepatol; 2012 Jan; 27(1):11-20. PubMed ID: 21916992
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
[TBL] [Abstract][Full Text] [Related]
32. Management of refractory ascites.
Singhal S; Baikati KK; Jabbour II; Anand S
Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
[TBL] [Abstract][Full Text] [Related]
33. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
34. Management of the Adult Patient with Cirrhosis Complicated by Ascites.
Nobbe AM; McCurdy HM
Crit Care Nurs Clin North Am; 2022 Sep; 34(3):311-320. PubMed ID: 36049850
[TBL] [Abstract][Full Text] [Related]
35. TIPS for management of refractory ascites: response and survival are both unpredictable.
Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
[TBL] [Abstract][Full Text] [Related]
36. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
Pose E; Cardenas A
Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
[TBL] [Abstract][Full Text] [Related]
37. Radiologically Placed Peritoneovenous Shunt is an Acceptable Treatment Alternative for Refractory Ascites Due to End-Stage Liver Disease.
Bakhtiar M; Forde KA; Nadolski GJ; Soulen MC; Weinberg EM
J Vasc Interv Radiol; 2021 Nov; 32(11):1606-1614. PubMed ID: 34416366
[TBL] [Abstract][Full Text] [Related]
38. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
39. Refractory Ascites in Liver Cirrhosis.
Adebayo D; Neong SF; Wong F
Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
[TBL] [Abstract][Full Text] [Related]
40. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
